Didier Saurigny Selected Research

Arthralgia (Joint Pain)

11/2020

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Didier Saurigny Research Topics

Disease

6	Rheumatoid Arthritis 12/2023 - 01/2015
3	Pain (Aches) 12/2023 - 11/2020
2	Rheumatic Diseases (Rheumatism) 11/2020 - 11/2020
2	Nasopharyngitis 11/2020 - 01/2019
2	Myocardial Infarction 11/2020 - 01/2019
1	Chronic Disease (Chronic Diseases) 12/2023
1	Fatigue 12/2023
1	Osteitis 11/2020
1	Ankle Fractures 11/2020
1	Arthralgia (Joint Pain) 11/2020
1	Cough 11/2020
1	Pyelonephritis 11/2020
1	Dizziness (Lightheadedness) 11/2020
1	Spasm (Spasms) 11/2020
1	Synovitis 11/2020
1	Leiomyoma (Uterine Fibroids) 11/2020
1	Necrosis 01/2019
1	Bronchitis 01/2019
1	Headache (Headaches) 01/2019

Drug/Important Bio-Agent (IBA)

6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023 - 01/2015
4	OtilimabIBA 12/2023 - 11/2020
3	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 01/2019
2	LigandsIBA 11/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 01/2015
1	sarilumabIBA 12/2023
1	tofacitinibIBA 12/2023
1	Janus Kinase InhibitorsIBA 12/2023
1	Macrophage Colony-Stimulating FactorIBA 12/2023
1	Antirheumatic Agents (DMARD)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	CC ChemokinesIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Biological FactorsIBA 01/2019
1	namilumabIBA 01/2019
1	mavrilimumabIBA 01/2015

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2019